High-constitutive HuR phosphorylation at Ser 318 by PKCδ propagates tumor relevant functions in colon carcinoma cells
Authors:
- Christine WinklerCWChristine Winkler
- Irina AzrilianIAIrina Azrilian
- Sebastian SchulzSSSebastian Schulz
- Sylvia HartmannSHSylvia Hartmann
- Josef PfeilschifterJPJosef Pfeilschifter
- Wolfgang EberhardtWEWolfgang Eberhardt
- 10 February 2011
- journal article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 32 (5) , 676-685
Abstract
Overexpression of the messenger RNA (mRNA)-binding protein HuR is an important feature of many tumors and in most cases correlates with a high-grade malignancy. Since phosphorylation of HuR by protein kinase C δ (PKCδ) at serine (Ser) 318 implies an important mode in HuR regulation, we studied its functional role in dysregulated HuR and related functions in colon carcinoma cells. Coimmunoprecipitation experiments revealed a high-constitutive association of nuclear PKCδ with HuR. Using a phospho-Ser 318-specific HuR antibody, we found a strong increase in nuclear HuR phosphorylation in DLD-1 cells when compared with nontransformed CCD 841 colon epithelial cells. Importantly, a strong increase in HuR phosphorylation at Ser 318 was also found in tissue specimen from human colon carcinomas. Employing ribonucleoprotein-immunoprecipitation, we show that DLD-1 cells displayed a strong and constitutive RNA binding of HuR to cyclooxygenase-2 (COX-2) and cyclin A encoding mRNAs that was strongly impaired by rottlerin, an inhibitor of novel PKCs. Accordingly, rottlerin accelerated the decay of COX-2 and cyclin A encoding mRNAs concomitant with a reduced expression of both genes. Functionally, migration and invasion is similarly impaired in PKCδ- or HuR-small interfering RNA-depleted cells and in tumor cells transfected with a nonphosphorylatable serine-to-alanine 318 HuR construct. Conversely, expression of a phosphomimetic Ser 318 aspartic acid (D) HuR caused a significant increase in migration and proliferation of CCD 841 cells. Our data suggest that the increased HuR phosphorylation at Ser 318 by PKCδ reflects an important regulatory paradigm for aberrant HuR functions and emphasize the antitumorigenic potential of PKCδ inhibitory strategies.Keywords
This publication has 36 references indexed in Scilit:
- The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine KinaseCancer Research, 2009
- Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuRCellular Signalling, 2008
- Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotypeOncogene, 2008
- Posttranscriptional Orchestration of an Anti-Apoptotic Program by HuRCell Cycle, 2007
- Modulation of mRNA stability as a novel therapeutic approachPharmacology & Therapeutics, 2007
- Cytoplasmic HuR Expression Is a Prognostic Factor in Invasive Ductal Breast CarcinomaCancer Research, 2005
- HuR: Post-Transcriptional Paths to MalignancyRNA Biology, 2005
- Expression of the ELAV-Like Protein HuR Is Associated with Higher Tumor Grade and Increased Cyclooxygenase-2 Expression in Human Breast CarcinomaClinical Cancer Research, 2004
- Overexpression of HuR, a nuclear–cytoplasmic shuttling protein, increases the in vivo stability of ARE‐containing mRNAsThe EMBO Journal, 1998
- Cloning and Characterization of HuR, a Ubiquitously Expressed Elav-like ProteinJournal of Biological Chemistry, 1996